We build the software that turns a genome into a decision you can sign.
A traceable genomic interpretation company based in Madrid, giving laboratories one automated platform from raw sequencing data to a reviewable, signable report.
Sequencing became routine. Interpreting it safely did not.
Most laboratories still stitch together a chain of separate tools — one for alignment, another for annotation, another for interpretation — and hope nothing is lost between them.
Too often something is. Variants in hard-to-map genes come back as a silent false normal: the report looks clean, but the finding was never seen. For any genomics laboratory that is the most dangerous kind of error, because nobody knows it happened.
Innovare exists to close that gap — to build interpretation software that makes its own limits visible, shows its reasoning, and hands a geneticist a decision they can review and sign with confidence.
Clinical genetics and software engineering, in the same person
Innovare is built at the intersection of two disciplines that rarely sit together. That hybrid perspective shapes every decision — from how the ACMG engine records its reasoning, to why polygenic scores are explicitly calibrated for the populations our clients actually serve.
ACMG/AMPClinGenCPICThree commitments we are willing to be held to
Rigour over hype
Every claim on this site is one a geneticist would defend in front of an auditor. We market the science; we do not inflate it. Where a capability is not ready, it says so.
Nothing is a black box
An interpretation you cannot inspect is one you cannot trust. The reasoning, the evidence and the limits are always visible, including the criteria that were deliberately not applied.
The expert signs
Software proposes; the geneticist decides and signs. We build the tool, not the verdict — and the responsibility stays where the professional accountability already is.
Research Use Only, stated plainly
Innovare is delivered as Research Use Only (RUO) software: a genomic-interpretation tool for research. It has not been validated as clinical software and is not for use in diagnostic procedures.
It does not diagnose, treat or prevent disease — it makes the evidence reviewable, and its results are research estimates that require review by a qualified professional.
This position describes the platform software. Genomic services are a separate offer, described on their own page.
Where our responsibility ends
We supply the research software, the analytical dossiers and the methodology. Your team performs its own validation, exercises the curation and signs off each research report. That boundary is deliberate, and it is written into the product.
Talk to us about your workflow
We work with research laboratories, hospital research groups, pharma and research centres in Spain, Europe and Latin America.